Aliases & Classifications for Egasyn

MalaCards integrated aliases for Egasyn:

Name: Egasyn 58
Esterase 22; Es22 58
Esterase 22 58
Es22 58

External Ids:

OMIM 58 129905

Summaries for Egasyn

MalaCards based summary : Egasyn, is also known as esterase 22; es22. An important gene associated with Egasyn is CES1 (Carboxylesterase 1), and among its related pathways/superpathways is Drug metabolism - cytochrome P450. The drugs Tacrolimus and Calcineurin Inhibitors have been mentioned in the context of this disorder. Affiliated tissues include liver and kidney, and related phenotype is adipose tissue.

Description from OMIM: 129905

Related Diseases for Egasyn

Symptoms & Phenotypes for Egasyn

Clinical features from OMIM:

129905

MGI Mouse Phenotypes related to Egasyn:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 adipose tissue MP:0005375 8.62 CES1 GUSB

Drugs & Therapeutics for Egasyn

Drugs for Egasyn (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 55)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tacrolimus Approved, Investigational Phase 4 104987-11-3 6473866 445643 439492
2 Calcineurin Inhibitors Phase 4
3 Immunologic Factors Phase 4,Phase 1,Phase 2,Not Applicable
4 Liver Extracts Phase 4
5 Immunosuppressive Agents Phase 4
6
Remifentanil Approved Phase 3 132875-61-7 60815
7
Propofol Approved, Investigational, Vet_approved Phase 3 2078-54-8 4943
8
Heparin Approved, Investigational Phase 3 9005-49-6 46507594 772
9
Bivalirudin Approved, Investigational Phase 3 128270-60-0 16129704
10
Calcium Approved, Nutraceutical Phase 3 7440-70-2 271
11
Serine Approved, Nutraceutical Phase 3 56-45-1 5951
12 Analgesics Phase 3,Phase 1
13 Anesthetics Phase 3
14 Peripheral Nervous System Agents Phase 3,Phase 1
15 Analgesics, Opioid Phase 3
16 Central Nervous System Depressants Phase 3,Phase 1
17 Narcotics Phase 3
18
protease inhibitors Phase 3
19 polysaccharide-K Phase 3
20 Antithrombins Phase 3
21 Hirudins Phase 3
22 Anticoagulants Phase 3
23 calcium heparin Phase 3
24 Antithrombin III Phase 3
25 Fibrinolytic Agents Phase 3,Phase 1
26 HIV Protease Inhibitors Phase 3
27 Calcium, Dietary Phase 3
28 Serine Proteinase Inhibitors Phase 3
29 Anti-Retroviral Agents Phase 1, Phase 2
30 Vaccines Phase 1, Phase 2
31 Antiviral Agents Phase 1, Phase 2
32 Anti-Infective Agents Phase 1, Phase 2
33 Histone Deacetylase Inhibitors Phase 1, Phase 2
34
Irinotecan Approved, Investigational Phase 1 100286-90-6, 97682-44-5 60838
35 Orange Approved Phase 1
36
Aspirin Approved, Vet_approved Phase 1 50-78-2 2244
37
Ethanol Approved Phase 1 64-17-5 702
38
Oseltamivir Approved Phase 1 204255-11-8, 196618-13-0 65028
39 Interleukin-12 Phase 1
40 Angiogenesis Inhibitors Phase 1
41 Adjuvants, Immunologic Phase 1,Not Applicable
42 Angiogenesis Modulating Agents Phase 1
43 topoisomerase I inhibitors Phase 1
44 Topoisomerase Inhibitors Phase 1
45 Antipyretics Phase 1
46 Platelet Aggregation Inhibitors Phase 1
47 Anti-Inflammatory Agents Phase 1
48 Cyclooxygenase Inhibitors Phase 1
49 Analgesics, Non-Narcotic Phase 1
50 Antirheumatic Agents Phase 1

Interventional clinical trials:

(show all 12)
# Name Status NCT ID Phase Drugs
1 A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients Terminated NCT01371344 Phase 4 Tacrolimus granules;Tacrolimus capsules
2 Low Remifentanil Target Controlled Infusions for Cardiac Surgery Recruiting NCT02033629 Phase 3 Ce 1 ng/ml;Ce 2 ng/ml;Ce 3 ng/ml
3 Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial Terminated NCT02448550 Phase 3 Bivalirudin;Unfractionated heparin
4 HIV-1-Gag Conserved-Element DNA Vaccine as Therapeutic Vaccination in HIV-Infected Persons With Viral Suppression on Antiretroviral Therapy Recruiting NCT03560258 Phase 1, Phase 2
5 Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC) Active, not recruiting NCT02759601 Phase 1, Phase 2 Tefinostat
6 Evaluating the Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA by Intramuscular Electroporation, in Healthy, HIV-Uninfected Adults Active, not recruiting NCT03181789 Phase 1
7 Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas Recruiting NCT02192359 Phase 1 irinotecan hydrochloride
8 Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas Withdrawn NCT02055196 Phase 1 irinotecan hydrochloride
9 Alcohol Inhibits Drug Metabolism by Carboxylesterases Completed NCT01708369 Phase 1 Placebo;Ethanol;Oseltamivir;Aspirin
10 An Evaluation of the Spectra Optia CMNC Collection Procedure Completed NCT02253160 Not Applicable Granulocyte-colony stimulating factor (G-CSF)
11 MR Assessment of Hepatic Hydatid Disease Recruiting NCT03289884
12 Three M Study (Malabsorption, Microbiota, Mini-Gastric Bypass) Recruiting NCT03412149 Not Applicable

Search NIH Clinical Center for Egasyn

Genetic Tests for Egasyn

Anatomical Context for Egasyn

MalaCards organs/tissues related to Egasyn:

42
Liver, Kidney

Publications for Egasyn

Articles related to Egasyn:

(show all 22)
# Title Authors Year
1
Human egasyn binds beta-glucuronidase but neither the esterase active site of egasyn nor the C terminus of beta-glucuronidase is involved in their interaction. ( 10562416 )
1999
2
Identification and androgen regulation of egasyn in the mouse epididymis. ( 9531973 )
1998
3
The beta-glucuronidase propeptide contains a serpin-related octamer necessary for complex formation with egasyn esterase and for retention within the endoplasmic reticulum. ( 7744842 )
1995
4
Cloning and sequencing of rat liver carboxylesterase ES-3 (egasyn). ( 7945287 )
1994
5
The signal for retention of the egasyn-glucuronidase complex within the endoplasmic reticulum. ( 8346916 )
1993
6
Expression of egasyn-esterase in mammalian cells. Sequestration in the endoplasmic reticulum and complexation with beta-glucuronidase. ( 2007590 )
1991
7
Characterization and functional expression of a cDNA encoding egasyn (esterase-22): the endoplasmic reticulum-targeting protein of beta-glucuronidase. ( 1783403 )
1991
8
Strain differences of rat liver carboxylesterase activities related to the phenotype difference of esterase-3 (egasyn). ( 2609020 )
1989
9
Egasyn affects the processing of beta-glucuronidase in mouse liver. ( 3214427 )
1988
10
Lumenal location of the microsomal beta-glucuronidase-egasyn complex. ( 3667691 )
1987
11
Involvement of the esterase active site of egasyn in compartmentalization of beta-glucuronidase within the endoplasmic reticulum. ( 3594574 )
1987
12
An accessory protein identical to mouse egasyn is complexed with rat microsomal beta-glucuronidase and is identical to rat esterase-3. ( 3294829 )
1987
13
The egasyn gene affects the processing of oligosaccharides of lysosomal beta-glucuronidase in liver. ( 3101673 )
1986
14
Identity of esterase-22 and egasyn, the protein which complexes with microsomal beta-glucuronidase. ( 3729927 )
1986
15
Egasyn, a protein which determines the subcellular distribution of beta-glucuronidase, has esterase activity. ( 4066695 )
1985
16
Preparation of microsomal beta-glucuronidase and its membrane anchor protein, egasyn. ( 6656645 )
1983
17
The synthesis and processing of beta-glucuronidase in normal and egasyn deficient mouse kidney. ( 7236294 )
1981
18
Inheritance in mice of the membrane anchor protein egasyn: the Eg locus determines egasyn levels. ( 849245 )
1977
19
Relationships between levels of membrane-bound glucuronidase and the associated protein egasyn in mouse tissues. ( 873997 )
1977
20
Phenobarbital induction of egasyn: availability of egasyn in vivo determines glucuronidase binding to membrane. ( 1267808 )
1976
21
Isolation, characterization, and radioimmunoassay of murine egasyn, a protein stabilizing glucuronidase membrane binding. ( 826534 )
1976
22
Egasyn, a protein complexed with microsomal beta-glucuronidase. ( 1112792 )
1975

Variations for Egasyn

Expression for Egasyn

Search GEO for disease gene expression data for Egasyn.

Pathways for Egasyn

GO Terms for Egasyn

Sources for Egasyn

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....